Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies

116Citations
Citations of this article
159Readers
Mendeley users who have this article in their library.

Abstract

Glioblastoma is the most aggressive form of malignant brain tumor. Standard treatment protocols and traditional immunotherapy are poorly effective as they do not significantly increase the long-term survival of glioblastoma patients. Oncolytic viruses (OVs) may be an effective alternative approach. Combining OVs with some modern treatment options may also provide significant benefits for glioblastoma patients. Here we review virotherapy for glioblastomas and describe several OVs and their combination with other therapies. The personalized use of OVs and their combination with other treatment options would become a significant area of research aiming to develop the most effective treatment regimens for glioblastomas.

Cite

CITATION STYLE

APA

Hamad, A., Yusubalieva, G. M., Baklaushev, V. P., Chumakov, P. M., & Lipatova, A. V. (2023, February 1). Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies. Viruses. MDPI. https://doi.org/10.3390/v15020547

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free